SC
Sangeetha Chettupally
About Sangeetha Chettupally
Data last updated:
Sangeetha Chettupally is a Director at Silantro Pharma Private Limited (since 2021). The companies operate in Food And Beverages and Pharma. Silantro Pharma Private Limited reported revenue of ₹31.4 Lakh (FY 2025). Earlier, Sangeetha Chettupally was a Director at Unicept Pharma Private Limited (2018–2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 19 Feb 2021 | 2021 | ₹31.4 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 18 Apr 2018 | 2013 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sangeetha Chettupally
| Name | DIN | Company | Designation |
|---|---|---|---|
| Gandla Sushma | 09074207 | Silantro Pharma Private Limited | Director |
| Suresh Dumala | 10827609 | Silantro Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sangeetha Chettupally
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sangeetha Chettupally
Sangeetha Chettupally currently holds 1 directorship: Silantro Pharma Private Limited (Director, since 19 Feb 2021, revenue ₹31.4 Lakh (FY 2025)).
Sangeetha Chettupally was first appointed on 18 Apr 2018 as Director at Unicept Pharma Private Limited. The most recent appointment on record is 19 Feb 2021 at Silantro Pharma Private Limited.
Sangeetha Chettupally held 1 earlier board appointment: Unicept Pharma Private Limited (Director, 18 Apr 2018 to 18 Feb 2019).
The current boards of Sangeetha Chettupally's companies include Gandla Sushma (Silantro Pharma Private Limited), Suresh Dumala (Silantro Pharma Private Limited).